SmartPharm Therapeutics, Inc. Employee Directory
Biotechnology ResearchMassachusetts, United States2-10 Employees
SmartPharm Therapeutics, Inc., now a subsidiary of Sorrento Therapeutics, is a Cambridge, Massachusetts–based biotechnology company focused on gene therapies that deploy non-viral DNA and RNA approaches to address serious human diseases. A key emphasis is on developing treatments for rare diseases, including lysosomal storage disorders. It positions itself as a second-generation, gene-encoded therapeutics company, combining lessons learned from early gene therapy with engineering capabilities to optimize products for patients. Its target market comprises patients with rare diseases and clinicians seeking gene-based treatment options. With a small team, the company operates within the broader Sorrento organization and concentrates on advancing non-viral gene therapies.